T. Rowe Price Associates »

Poseida Therapeutics I shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $56k 17k 3.39
2023-09-30 $33k 14k 2.39
2023-06-30 $25k 14k 1.81

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Poseida Therapeutics I

Pentwater Capital Management
Vanguard Group
Aisling Capital Management
William Blair $ Company
Millennium Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Point72 Asset Management
MCF Advisors
Bank of America Corporation
Bank of New York Mellon
Barclays

View all funds holding Poseida Therapeutics I